Epidermal Growth Factor Receptor Antagonist [EPC] - N0000175664

Pharmacologic Code	N0000175664
Pharmacologic Name	Epidermal Growth Factor Receptor Antagonist
Pharmacologic Uses	epidermal growth factor receptor (EGFR) antagonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 5 products whose active ingredient are classified under the same pharmacologic class Epidermal Growth Factor Receptor Antagonist [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0002-7716	Portrazza	Non-Proprietary Name: Necitumumab	Solution	Intravenous	Eli Lilly And Company	ACTIVE
	55513-954	Vectibix	Non-Proprietary Name: Panitumumab	Solution	Intravenous	Amgen Inc	ACTIVE
	55513-956	Vectibix	Non-Proprietary Name: Panitumumab	Solution	Intravenous	Amgen Inc	ACTIVE
	66733-948	Erbitux	Non-Proprietary Name: Cetuximab	Solution	Intravenous	Imclone Llc	ACTIVE
	66733-958	Erbitux	Non-Proprietary Name: Cetuximab	Solution	Intravenous	Imclone Llc	ACTIVE